Culture of low passage colorectal cancer cells and demonstration of variation in selected tumour marker expression

被引:6
作者
Arul, Melanie [1 ]
Roslani, April Camilla [2 ]
Ng, Colin Leong Liong [3 ]
Cheah, Swee Hung [1 ]
机构
[1] Univ Malaya, Fac Med, Dept Physiol, Kuala Lumpur, Malaysia
[2] Univ Malaya, Fac Med, Dept Surg, Kuala Lumpur, Malaysia
[3] Tropicana Med Ctr, Petaling Jaya 47810, Selangor Darul, Malaysia
关键词
Colorectal; Cancer; Cell; Culture; Immunocytochemistry; PHENOTYPIC HETEROGENEITY; STEM-CELLS; LINES; MODEL; TRANSFORMATION; ESTABLISHMENT;
D O I
10.1007/s10616-013-9600-4
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 [微生物学]; 090105 [作物生产系统与生态工程];
摘要
There is increasing evidence that a tumour comprises of heterogeneous population of cells. Thus, studying homogenous cell lines in vitro may yield results that are not reflective of the true situation in a tumour and studying low passage cell lines maintained in a heterogeneous population before they transform away from the original state may provide a more complete picture of colorectal cancer. A method was developed to isolate and establish low passage colorectal cancer cell lines from tumour biopsies. The media contents, combination of antimicrobials and specimen collection and transport conditions employed, successfully eliminated microbial contamination which is frequently present in samples obtained from the gastrointestinal tract. A variety of growth forms indicating a heterogeneous mixture of cells was seen in the initial cultures. Using fluorescence immunocytochemistry, primary tumour cultures were shown to variably express selected tumour markers, carcinoembryonic antigen and C2 antigen. These low passage cell lines growing in a heterogeneous environment would more closely reflect the characteristics of the cells of the original tumour.
引用
收藏
页码:481 / 491
页数:11
相关论文
共 43 条
[1]
[Anonymous], 2011, CANCER
[2]
ATCC, 2007, ATCC TECHN B, V7
[3]
LONG-TERM CULTURE OF NORMAL HUMAN COLONIC EPITHELIAL-CELLS INVITRO [J].
BATEN, A ;
SAKAMOTO, K ;
SHAMSUDDIN, AM .
FASEB JOURNAL, 1992, 6 (09) :2726-2734
[4]
Botchkina Inna L., 2009, Cancer Genomics & Proteomics, V6, P19
[5]
BriskeAnderson MJ, 1997, P SOC EXP BIOL MED, V214, P248
[6]
Breast cancer cell lines: friend or foe? [J].
Burdall, SE ;
Hanby, AM ;
Lansdown, MRJ ;
Speirs, V .
BREAST CANCER RESEARCH, 2003, 5 (02) :89-95
[7]
Breast tumor heterogeneity [J].
Campbell, Lauren L. ;
Polyak, Kornelia .
CELL CYCLE, 2007, 6 (19) :2332-2338
[8]
Effect of passage number on cellular response to DNA-damaging agents: Cell survival and gene expression [J].
ChangLiu, CM ;
Woloschak, GE .
CANCER LETTERS, 1997, 113 (1-2) :77-86
[9]
Tumour markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines for clinical use [J].
Duffy, M. J. ;
van Dalen, A. ;
Haglund, C. ;
Hansson, L. ;
Holinski-Feder, E. ;
Klapdor, R. ;
Lamerz, R. ;
Peltomaki, P. ;
Sturgeon, C. ;
Topolcan, O. .
EUROPEAN JOURNAL OF CANCER, 2007, 43 (09) :1348-1360
[10]
LNCaP prostatic adenocarcinoma cells derived from low and high passage numbers display divergent responses not only to androgens but also to retinoids [J].
Esquenet, M ;
Swinnen, JV ;
Heyns, W ;
Verhoeven, G .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1997, 62 (5-6) :391-399